TITLE

Humoral Immune Response to Hepatitis C After Liver Transplantation: Assessment of a New Recombinant Immunoblot Assay

AUTHOR(S)
Rosen, Hugo R.; Gretch, David; Kaufman, Ezra; Quan, Stella
PUB. DATE
August 2000
SOURCE
American Journal of Gastroenterology;Aug2000, Vol. 95 Issue 8, p2035
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: The immune control of infection with hepatitis C virus (HCV) is poorly understood; vigorous antibody responses to viral proteins seem to coexist with the virus and thus whether they are neutralizing remains controversial. HCV-related liver failure is the leading indication for orthotopic liver transplantation (OLT) worldwide. Attenuated antibody responses in immunosuppressed patients and decreased reliability compared to assessment of HCV RNA has hampered the use of antibody testing post-OLT. The goals of this current analysis were twofold: to determine the sensitivity of a prototype strip immunoblot assay (RIBA 3.0, Chiron Diagnostics) for the diagnosis of HCV post-OLT; to determine if there was a correlation between antibody response and severity of histological recurrence. METHODS: The study was comprised of 76 HCV-positive individuals divided into three patient groups: liver allograft recipients with evidence of mild or no histological recurrence (n = 52). liver allograft recipients with evidence of severe HCV recurrence and allograft cirrhosis (n = 12), and nontransplant patients being enrolled in an induction interferon trial (n = 12). All transplant patients had histological follow-up of at least 1 yr. RESULTS: Sixty of the 64 (94%) HCV-positive OLT recipients had I + reactivity to two or more recombinant antigens: three of the patients who lacked a detectable response had minimal histological recurrence and one had severe recurrence. All nontransplant patients demonstrated 4+ re-activity to at least two antigens, and 55/64 (86%) OLT recipients demonstrated this same level of reactivity. Seven of the nine patients lacking this high level of reactivity had evidence of minimal recurrence. Furthermore, the mean (± SEM) level of antibody reactivity for c100 (p = 0.04) and NS5 (p = 0.01) were significantly lower for patients with mild recurrence after OLT, compared to the other groups. The level of antibody reactivity was unrelated to HCV genotype or viral load. CONCLUSIONS: The recently developed RIBA 3.0 assay for detection of antibodies to HCV appears to be highly sensitive for the diagnosis of HCV post-OLT. In general, the level of antibody reactivity was comparable in the transplant patients and in nonimmunosuppressed controls. The pathogenic implications of the relatively diminished humoral response in patients with mild recurrence post-OLT are discussed.
ACCESSION #
17651745

 

Related Articles

  • Liver Tolerance and the Manipulation of Immune Outcomes. Holz, Lauren E.; McCaughan, Geoffrey W.; Benseler, Volker; Bertolino, Patrick; Bowen, David G. // Inflammation & Allergy - Drug Targets;Mar2008, Vol. 7 Issue 1, p6 

    In recent years it has become apparent that the liver holds a distinct immunological position. Previously described as a "graveyard" for T cells activated in the periphery, emerging evidence indicates that this organ may have a more active role in mediating tolerance. Attenuated immune responses...

  • Neutralizing Antibodies and Pathogenesis of Hepatitis C Virus Infection. Fafi-Kremer, Samira; Fauvelle, Catherine; Felmlee, Daniel J.; Zeisel, Mirjam B.; Lepiller, Quentin; Fofana, Isabel; Heydmann, Laura; Stoll-Keller, Françoise; Baumert, Thomas F. // Viruses (1999-4915);Oct2012, Vol. 4 Issue 10, p2016 

    Hepatitis C virus (HCV) infection is a major cause of chronic liver disease worldwide. The interplay between the virus and host innate and adaptive immune responses determines the outcome of infection. There is increasing evidence that host neutralizing responses play a relevant role in the...

  • Clinical Transplantation and Tolerance: Are We There Yet? Saidi, R. F.; Hejazii Kenari, S. K. // International Journal of Organ Transplantation Medicine;2014, Vol. 5 Issue 4, p137 

    Organ transplantation is not only considered as the last resort therapy but also as the treatment of choice for many patients with end-stage organ damage. Recipient-mediated acute or chronic immune response is the main challenge after transplant surgery. Nonspecific suppression of host immune...

  • Liver transplantation or hepatitis C virus related liver disease. Gee, I.; Alexander, G. // Postgraduate Medical Journal;Dec2005, Vol. 81 Issue 962, p765 

    Liver transplantation is a useful treatment for end stage liver disease of all aetiologies but recurrent disease presents an ongoing challenge, particularly for hepatitis C virus (HCV) where recurrence is almost universal. Immunosuppression is needed for all patients after transplantation and...

  • NK Cells, Innate Immunity and Hepatitis C Infection after Liver Transplantation. Nellore, Anoma; Fishman, Jay A. // Clinical Infectious Diseases;Feb2011, Vol. 52 Issue 3, p369 

    Liver transplantation in patients with active hepatitis C virus (HCV) infection is followed by almost universal recurrence of viral infection. The control of HCV infection has been characterized largely in terms of the HCV-specific function of T-lymphocytes and the adaptive immune response....

  • Utilization of Acidophil Bodies in the Diagnosis of Recurrent Hepatitis C Infection after Orthotopic Liver Transplantation. Saxena, Romil; Crawford, James M.; Navarro, Victor J.; Friedman, Amy L.; Robert, Marie E. // Modern Pathology;Sep2002, Vol. 15 Issue 9, p897 

    Background: The distinction between acute rejection and early recurrent hepatitis C infection (RHCV) in the setting of orthotopic liver transplantation is often difficult. In liver biopsies addophil bodies and lobular hepatitis are used to suggest a diagnosis of RHCV over rejection, however, the...

  • Immunotherapy for hepatocellular carcinoma. Shuzhan Li; Fan Yang; Xiubao Ren // Drug Discoveries & Therapeutics;Oct2015, Vol. 9 Issue 5, p363 

    Hepatocellular carcinoma (HCC) is the most common type of hepatic malignancies, with poor prognosis. Treatment for HCC are limited, especially for patients with advanced disease who are not eligible for curative hepatectomy or hepatic transplantation. Mechanisms of immune response during tumor...

  • Short-circuiting regulatory T-cell proliferation during chronic infection. Liston, Adrian; Kim, Jeong M. // Immunology & Cell Biology;Aug2009, Vol. 87 Issue 6, p443 

    The article provides information on the condition of the regulatory T-cell proliferation in morbid infection. Accordingly, the Foxp3+ is responsible for the weakening of the regulatory T-cell proliferation, particularly during the attack of the hepatitis C virus (HCV). Moreover, the Foxp3+ is...

  • Hepatitis C Virus and Dendritic Cells. Agrawal, Babita // Current Immunology Reviews;2006, Vol. 2 Issue 4, p305 

    A majority of hepatitis C virus (HCV) infected individuals become chronically infected. There are approximately 175 million patients chronically infected with HCV worldwide. Multispecific and vigorous cellular immune responses against HCV antigens have been suggested to play a significant role...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics